Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AMPICILLIN TRIHYDRATE

AMPICILLIN/AMPICILLIN TRIHYDRATE

Standard Dose
EQ 250MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview AMPICILLIN TRIHYDRATE is listed in Drugs@FDA under application 062982 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMPICILLIN/AMPICILLIN TRIHYDRATE Form and strength FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML Sponsor PH HEALTH Submission history Latest submission status date: 2024-05-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMPICILLIN TRIHYDRATE is listed in Drugs@FDA under application 062982 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMPICILLIN/AMPICILLIN TRIHYDRATE Form and strength FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML Sponsor PH HEALTH Submission history Latest submission status date: 2024-05-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
AMPICILLIN TRIHYDRATE (AMPICILLIN/AMPICILLIN TRIHYDRATE) | Drug Monograph | MedicHelpline